Latest Articles
Women with endometriosis face fourfold higher risk of ovarian cancer, study suggests - CNN
Women with endometriosis face fourfold higher risk of ovarian cancer, study suggests CNN
Published: July 17, 2024, 7 a.m.
Women With Endometriosis Face ‘Markedly Increased’ Risk Of Ovarian Cancer, Study Suggests - Forbes
Women With Endometriosis Face ‘Markedly Increased’ Risk Of Ovarian Cancer, Study Suggests Forbes
Published: July 17, 2024, 7 a.m.
6 Things That Can Cause Ovarian Cysts - Health.com
6 Things That Can Cause Ovarian Cysts Health.com
Published: July 14, 2024, 7 a.m.
ROCSAN Study Step I Misses 16-Week ORR End Point in Endometrial or Ovarian Carcinosarcoma - OncLive
ROCSAN Study Step I Misses 16-Week ORR End Point in Endometrial or Ovarian Carcinosarcoma OncLive
Published: June 20, 2024, 7 a.m.
Endometriosis increases risks for ovarian, endometrial cancers - Healio
Endometriosis increases risks for ovarian, endometrial cancers Healio
Published: June 7, 2024, 7 a.m.
FDA grants breakthrough designation for ovarian cancer liquid biopsy - TechTarget
FDA grants breakthrough designation for ovarian cancer liquid biopsy TechTarget
Published: May 31, 2024, 7 a.m.
For some endometriosis-related ovarian cancers, timing is everything - Medical Xpress
For some endometriosis-related ovarian cancers, timing is everything Medical Xpress
Published: May 28, 2024, 7 a.m.
Estrogen-Only Therapy for Menopausal Symptoms Increases Ovarian Cancer Risk - Medpage Today
Estrogen-Only Therapy for Menopausal Symptoms Increases Ovarian Cancer Risk Medpage Today
Published: May 24, 2024, 7 a.m.
Mayo scientists explore swabs for early endometrial, ovarian cancer detection - Mayo Clinic
Mayo scientists explore swabs for early endometrial, ovarian cancer detection Mayo Clinic
Published: May 23, 2024, 7 a.m.
eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer - GlobeNewswire
eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous …
Published: May 20, 2024, 7 a.m.
Link copied to clipboard!